InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
47%
T+90 mean return
+1.8%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by GILMAN STEVEN C, Director. Officer active across 3 companies, notably Akebia Therapeutics, Inc.. Cumulatively, 25 filings have been logged. Split: 0 buy · 4 sells. Total volume traded: €53k. Activity tracked since 2 June 2021. The latest transaction was filed on 16 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations25 total
5,833 shares@ US$13.0520.1% of flowCommon StockSEC:0001140361-24-043695:0
5,833 shares@ US$13.0519.8% of flowCommon StockSEC:0001140361-24-042882:0
5,834 shares@ US$13.0519.7% of flowCommon StockSEC:0001140361-24-041562:0
5,000 shares@ US$3.744.8% of flowCommon StockSEC:0001140361-24-040228:0
23,000 shares0Common StockSEC:0000950170-24-076235:0
30,000 shares0Common StockSEC:0001562180-24-004906:0
3,200 sharesCommon StockSEC:0001140361-24-024332:0
10,000 shares0Common StockSEC:0000950170-23-029622:0
30,000 shares0Common StockSEC:0001562180-23-004954:0
2,600 sharesCommon StockSEC:0001140361-23-021499:0
10,000 shares0Common StockSEC:0001209191-22-038657:0
13,700 shares0Common StockSEC:0001562180-22-004975:0
4,567 shares@ US$0.3620.0005% mcap5.8% of flowCommon StockSEC:0001562180-22-004870:0
900 shares@ US$30.940.0016% mcap21.3% of flowCommon StockSEC:0001593968-22-000897:0
2,600 sharesCommon StockSEC:0001593968-22-000891:0
5,000 shares@ US$3.740.0010% mcap13.3% of flowCommon StockSEC:0001593968-21-002478:0
5,000 shares@ US$3.744.8% of flowCommon StockSEC:0001593968-21-002478
5,000 shares@ US$3.740.0010% mcap13.0% of flowCommon StockSEC:0001593968-21-002304:0
5,000 shares@ US$3.744.6% of flowCommon StockSEC:0001593968-21-002304
5,000 shares@ US$3.740.0010% mcap13.0% of flowCommon StockSEC:0001593968-21-002214:0
5,000 shares@ US$3.744.6% of flowCommon StockSEC:0001593968-21-002214
4,567 shares@ US$3.32020.0044% mcap47.1% of flowCommon StockSEC:0001562180-21-004152:0
4,567 shares@ US$3.320247.1% of flowCommon StockSEC:0001562180-21-004152
13,700 shares0Common StockSEC:0001562180-21-004027:0
13,700 shares0Common StockSEC:0001562180-21-004027
25 of 25 declarations
About GILMAN STEVEN C
Steven C. Gilman is an executive at Akebia Therapeutics, Inc.
